(888) 552-6760 SCHEDULE A CONSULTATION

Cancer Treatment Centers of America (CTCA) Chicago Recognized by U.S. News & World Report

July 26, 2022

Cancer Treatment Centers of America® (CTCA) Chicago, part of City of Hope, was recognized as a “high performing hospital” for prostate cancer surgery, lung cancer surgery and ovarian cancer surgery by U.S. News & World Report.

Released July 26, the widely regarded “Best Hospitals” rankings evaluated more than 4,500 hospitals and benchmarked each based on clinical outcomes, volume, nursing staffing, expert opinion and patient experience. CTCA Atlanta also ranked as a “high performing hospital” for prostate cancer surgery and lung cancer surgery.

“This honor belongs to our team – the difference-makers who drive clinical excellence, deliver compassionate care and serve patients and families from across the nation,” said Pete Govorchin, president and CEO of CTCA Chicago. “We are humbled by this recognition and renewed in our mission.”

Earlier this year, CTCA joined NCI-designated City of Hope, one of the largest cancer research and treatment organizations in the United States, to advance a mission to transform the future of cancer research and treatment by expanding access to world-class research and cancer care to patients nationally. City of Hope was recognized as the seventh “Best Hospital” for cancer in the nation according to U.S. News & World Report’s 2022-23 Best Hospitals: Specialty Ranking, marking the 16th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.

For more information on CTCA Chicago, visit cancercenter.com/chicago.

Complete lists of the U.S. News & World Report “Best Hospitals” by specialties and rating data are available online here.

About Cancer Treatment Centers of America

Cancer Treatment Centers of America (CTCA), part of City of Hope, is a national network of oncology hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA publishes treatment results biannually, including patient experience, length of life, quality of life, patient safety and quality of care. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.

City of Hope’s mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. As an independent, National Cancer Institute (NCI)-designated comprehensive cancer center, City of Hope reflects a uniquely integrated model spanning cancer care, research and development, academics and training, and innovation initiatives. For more information about City of Hope, follow us on Facebook, Twitter, YouTube, Instagram, or LinkedIn.